Viewing Study NCT04834024

Bugs

Ignite Creation Date: 2025-12-18 @ 8:12 AM

Ignite Modification Date: 2025-12-23 @ 9:56 PM

Study NCT ID: NCT04834024

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module